Millennium Management’s AnaptysBio ANAB Stock Holding History

Millennium Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.4M	Sell	475,572 -337,999	-42%	-$18.2M	0.01%	1318
2025 Q4	$39.4M	Sell	813,571 -705,659	-46%	-$27.5M	0.02%	976
2025 Q3	$46.5M	Buy	1,519,230 +1,315,688	+646%	+$30.2M	0.02%	928
2025 Q2	$4.52M	Buy	203,542 +185,735	+1,043%	+$3.89M	﹤0.01%	3094
2025 Q1	$331K	Sell	17,807 -128,710	-88%	-$2.15M	﹤0.01%	5046
2024 Q4	$1.94M	Sell	146,517 -185,049	-56%	-$4.48M	﹤0.01%	3674
2024 Q3	$11.1M	Sell	331,566 -42,196	-11%	-$1.44M	0.01%	2101
2024 Q2	$9.37M	Sell	373,762 -273,363	-42%	-$6.36M	﹤0.01%	2144
2024 Q1	$14.6M	Buy	647,125 +240,094	+59%	+$5.69M	0.01%	1823
2023 Q4	$8.72M	Sell	407,031 -39,186	-9%	-$676K	﹤0.01%	2310
2023 Q3	$8.01M	Buy	446,217 +49,028	+12%	+$936K	﹤0.01%	2264
2023 Q2	$8.08M	Buy	397,189 +137,076	+53%	+$2.78M	﹤0.01%	2225
2023 Q1	$5.66M	Sell	260,113 -62,689	-19%	-$1.52M	﹤0.01%	2498
2022 Q4	$10M	Buy	322,802 +294,750	+1,051%	+$8.32M	0.01%	2118
2022 Q3	$716K	Sell	28,052 -2,234	-7%	-$52.4K	﹤0.01%	4635
2022 Q2	$615K	Buy	+30,286	New	+$671K	﹤0.01%	4789
2022 Q1	–	Sell	-18,051	Closed	-$627K	–	6861
2021 Q4	$627K	Sell	18,051 -114,658	-86%	-$3.64M	﹤0.01%	4846
2021 Q3	$3.6M	Buy	132,709 +25,189	+23%	+$639K	﹤0.01%	3257
2021 Q2	$2.79M	Buy	+107,520	New	+$2.58M	﹤0.01%	3537
2021 Q1	–	Sell	-70,995	Closed	-$1.79M	–	5868
2020 Q4	$1.53M	Sell	70,995 -217,169	-75%	-$5.27M	﹤0.01%	3440
2020 Q3	$4.25K	Buy	288,164 +171,437	+147%	+$3.09M	0.01%	1988
2020 Q2	$2.61M	Sell	116,727 -104,510	-47%	-$1.91M	﹤0.01%	2329
2020 Q1	$3.13M	Sell	221,237 -402,779	-65%	-$6.11M	0.01%	1700
2019 Q4	$10.1M	Sell	624,016 -409,522	-40%	-$9.69M	0.01%	1362
2019 Q3	$36.2M	Buy	1,033,538 +94,600	+10%	+$4.5M	0.06%	446
2019 Q2	$53M	Buy	938,938 +485,974	+107%	+$35M	0.08%	322
2019 Q1	$33.1M	Buy	452,964 +194,340	+75%	+$13.4M	0.05%	523
2018 Q4	$16.5M	Buy	258,624 +166,456	+181%	+$12.4M	0.03%	805
2018 Q3	$9.2M	Sell	92,168 -143,105	-61%	-$11.9M	0.01%	1381
2018 Q2	$16.7M	Sell	235,273 -74,188	-24%	-$6.22M	0.02%	972
2018 Q1	$32.2M	Buy	309,461 +130,686	+73%	+$14.7M	0.04%	637
2017 Q4	$18M	Sell	178,775 -147,117	-45%	-$10.8M	0.02%	966
2017 Q3	$11.4M	Buy	325,892 +277,500	+573%	+$7.49M	0.02%	1163
2017 Q2	$1.16M	Sell	48,392 -101,114	-68%	-$2.54M	﹤0.01%	2374
2017 Q1	$4.15M	Buy	+149,506	New	+$3.48M	0.01%	1565

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management's ANAB Position: Q1 2026 in Review

Millennium Management reduced its AnaptysBio (ANAB) stake by 42% in Q1 2026, selling an estimated $18.2M and leaving 475,572 shares worth $26.4M. The position accounts for 0.01% of the portfolio, ranked #1318.

Millennium Management first reported a position in ANAB in Q1 2017 and has held it in 35 quarters since. The position peaked at $53M in Q2 2019. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Millennium Management held 475,572 shares of AnaptysBio worth $26.4M as of Q1 2026.
Millennium Management sold 337,999 AnaptysBio shares in Q1 2026, an estimated $18.2M.
AnaptysBio made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1318 holding.
Millennium Management first reported a position in AnaptysBio in Q1 2017 and has held it in 35 quarters since.
Millennium Management's AnaptysBio position peaked at $53M in Q2 2019.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.